Thienocinnolinone Alkanoic Acid Derivatives as Aldose Reductase Inhibitors

Authors: Pau, A.; Asproni, B.; Murineddu, G.; Boatto, G.; Grella, G. E.; Rakowitz, D.; Costantino, L.; Pinna, G. A.

Source: Medicinal Chemistry, Volume 2, Number 1, January 2006 , pp. 39-45(7)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $62.88 plus tax (Refund Policy)

Abstract:

A new series of 8-halogen-4,4a,5,6-tetrahydrothieno[2,3-h]cinnolinone-N2-alkanoic acids was prepared and tested for aldose reductase (ALR2) inhibitory activities. These compounds showed significant inhibitory activity against bovine lens ALR2, with the best compound 2e showing an IC50 value of 31.4 μM. The presence of the C8-substituents here studied (Cl, Br) on the thienocinnolinone scaffold caused a decrease of the inhibitory potency by a factor of about 4 with respect to the unsubstituted parent compound, while the presence of a C8-methyl group, considered in a previous paper [1] decreased the activity by a factor of about 2. Moreover, the length of the N2 alkanoic chain influences strongly the enzyme inhibitory activity. While most of the carboxylic acids ALR2 inhibitors are acetic acid derivatives, in the case of thienocinnolinone compounds, homologues higher than acetic acids showed to be more active.

Keywords: Diabetic complications; aldose reductase inhibitors; thieno[h]cinnolinone carboxylic acids

Document Type: Research article

Affiliations: 1: Dipartimento Farmaco Chimico Tossicologico,Universita di Sassari, Muroni 23/A, 07100 Sassari, Italy.

Publication date: 2006-01-01